LOW vs REPL
Lowe's Companies Inc (LOW) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
REPL does not have a complete income-statement cache yet.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. REPL currently screens at market cap $825.7M.
Not investment advice. Open the LOW and REPL stock pages for the full models.
Not investment advice.